Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Calpain inhibitors jointly developed by SKB and Cephalon

Oct. 29, 1998

(+)-Enantiomer of known compound acts as potent, selective NMDA receptor antagonist

Oct. 29, 1998

Alpha2-adrenoceptor antagonists useful as adjuncts to L-DOPA in PD

Oct. 28, 1998

Ionotropic glutamate receptor ligands described by Lilly for CNS disorders

Oct. 28, 1998

CoCensys announces clinical results from phase II migraine trial

Oct. 28, 1998

No risk of liver toxicity with entacapone, Orion says

Oct. 27, 1998

AxyS reaches research milestones in collaboration with Warner-Lambert

Oct. 27, 1998

Pharmacokinetic and therapeutic equivalence of Zelapar and Eldepryl

Oct. 27, 1998

New serotonergic agents in development at ADIR for CNS disorders

Oct. 27, 1998

Yamanouchi discloses 5-HT2C receptor agonists with high potency and selectivity

Oct. 27, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...